{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:51:57Z","timestamp":1785498717645,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ygyno.2016.03.011","type":"journal-article","created":{"date-parts":[[2016,4,3]],"date-time":"2016-04-03T12:34:31Z","timestamp":1459686871000},"page":"501-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Brachytherapy improves survival in primary vaginal cancer"],"prefix":"10.1016","volume":"141","author":[{"given":"Andrew","family":"Orton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Boothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ned","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2265-0947","authenticated-orcid":false,"given":"Thomas","family":"Buchmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Jessica","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Suneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Poppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.03.011_bb0005","series-title":"SEER Cancer Statistics Review","year":"1975"},{"key":"10.1016\/j.ygyno.2016.03.011_bb0010","series-title":"Cancer of the Cervix, Vagina, and Vulva","author":"Eifel","year":"2008"},{"issue":"2","key":"10.1016\/j.ygyno.2016.03.011_bb0015","first-page":"241","article-title":"Primary carcinoma of the vagina","volume":"15","author":"Lilic","year":"2010","journal-title":"J. BUON"},{"issue":"1","key":"10.1016\/j.ygyno.2016.03.011_bb0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ygyno.2011.12.449","article-title":"Human papillomavirus as a favorable prognostic biomarker in squamous cell carcinomas of the vagina","volume":"125","author":"Alonso","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.011_bb0025","series-title":"Human Papillomavirus\u2013Associated Cancers \u2014 United States, 2004\u20132008","author":"(CDC) CfDCaP","year":"2012"},{"issue":"1","key":"10.1016\/j.ygyno.2016.03.011_bb0030","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2004.09.032","article-title":"Definitive radiation therapy for squamous cell carcinoma of the vagina","volume":"62","author":"Frank","year":"2005","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ygyno.2016.03.011_bb0035","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0360-3016(95)02394-1","article-title":"Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors","volume":"35","author":"Chyle","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ygyno.2016.03.011_bb0040","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/1097-0142(1971)28:5<1278::AID-CNCR2820280528>3.0.CO;2-O","article-title":"Irradiation of in-situ' and invasive squamous cell carcinomas of the vagina","volume":"28","author":"Brown","year":"1971","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2016.03.011_bb0045","first-page":"436","article-title":"Effectiveness of radiotherapy in patients with primary invasive vaginal carcinoma","volume":"34","author":"Blecharz","year":"2013","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.011_bb0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1748-717X-3-7","article-title":"High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina","volume":"3","author":"Beriwal","year":"2008","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.03.011_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.prro.2014.03.004","article-title":"Patterns of care and brachytherapy boost utilization for vaginal cancer in the United States","volume":"5","author":"Rajagopalan","year":"2015","journal-title":"Pract. Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2016.03.011_bb0060","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2013.05.033","article-title":"Trends in the utilization of brachytherapy in cervical cancer in the United States","volume":"87","author":"Han","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ygyno.2016.03.011_bb0065","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2307\/3001616","article-title":"Some methods for strengthening the common \u03c72 tests","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"issue":"3","key":"10.1016\/j.ygyno.2016.03.011_bb0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2105\/AJPH.79.3.340","article-title":"Modeling and variable selection in epidemiologic analysis","volume":"79","author":"Greenland","year":"1989","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ygyno.2016.03.011_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"3","key":"10.1016\/j.ygyno.2016.03.011_bb0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivar. Behav. Res."},{"issue":"2","key":"10.1016\/j.ygyno.2016.03.011_bb0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm. Stat."},{"issue":"1","key":"10.1016\/j.ygyno.2016.03.011_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","article-title":"Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations","volume":"51","author":"Austin","year":"2009","journal-title":"Biom. J."},{"issue":"3","key":"10.1016\/j.ygyno.2016.03.011_bb0095","doi-asserted-by":"crossref","first-page":"263","DOI":"10.18553\/jmcp.2003.9.3.263","article-title":"Cost and utilization comparisons among propensity score-matched insulin lispro and regular insulin users","volume":"9","author":"Hall","year":"2003","journal-title":"J. Manag. Care Pharm."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2016.03.011_bb0100","first-page":"II9","article-title":"Patient selection and current practice strategy for off-pump coronary artery bypass surgery","volume":"108","author":"Magee","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ygyno.2016.03.011_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.publhealth.20.1.145","article-title":"Time-dependent covariates in the Cox proportional-hazards regression model","volume":"20","author":"Fisher","year":"1999","journal-title":"Annu. Rev. Public Health"},{"issue":"7","key":"10.1016\/j.ygyno.2016.03.011_bb0110","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/sim.5984","article-title":"The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments","volume":"33","author":"Austin","year":"2014","journal-title":"Stat. Med."},{"issue":"4","key":"10.1016\/j.ygyno.2016.03.011_bb0115","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ijrobp.2008.03.032","article-title":"Image-guided radiotherapy for cervix cancer: high-tech external beam therapy versus high-tech brachytherapy","volume":"71","author":"Georg","year":"2008","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"23","key":"10.1016\/j.ygyno.2016.03.011_bb0120","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1200\/JCO.2004.12.193","article-title":"Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy","volume":"22","author":"Huguenin","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2016.03.011_bb0125","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.ygyno.2016.03.011_bb0130","first-page":"77","article-title":"The influence of radiation therapy dose escalation on overall survival in unresectable pancreatic adenocarcinoma","volume":"5","author":"Hall","year":"2014","journal-title":"J. Gastrointest. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2016.03.011_bb0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.currproblcancer.2012.03.008","article-title":"Using the Surveillance, Epidemiology, and End Results database to investigate rare cancers, second malignancies, and trends in epidemiology, treatment, and outcomes","volume":"36","author":"Lloyd","year":"2012","journal-title":"Curr. Probl. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2016.03.011_bb0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.currproblcancer.2012.03.011","article-title":"Limitations and biases of the Surveillance, Epidemiology, and End Results database","volume":"36","author":"Park","year":"2012","journal-title":"Curr. Probl. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2016.03.011_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065048","article-title":"Concurrent chemoradiation for vaginal cancer","volume":"8","author":"Miyamoto","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.ygyno.2016.03.011_bb0150","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ijrobp.2007.04.015","article-title":"Primary vaginal cancer treated with concurrent chemoradiation using Cis-platinum","volume":"69","author":"Samant","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T23:50:23Z","timestamp":1655423423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816300683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0090825816300683"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.03.011","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brachytherapy improves survival in primary vaginal cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}